Aberdeen Group’s Fulcrum Therapeutics FULC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$404K	Buy	+58,696	New	+$404K	﹤0.01%	901
2024 Q3	–	Sell	-256,888	Closed	-$1.59M	–	936
2024 Q2	$1.59M	Hold	256,888	–	–	﹤0.01%	777
2024 Q1	$2.43M	Hold	256,888	–	–	﹤0.01%	755
2023 Q4	$1.73M	Buy	+256,888	New	+$1.73M	﹤0.01%	785